Connect with us

National

Advancing the Diagnosis and Treatment of Ovarian Cancer – News-Medical.net

In this interview, News-Medical talks to Dr. Marcos Quintela Vasquez about the work he is conducting
regarding the diagnosis and treatment of ovarian cancer in…

Published

on

Article feature image

In this interview, News-Medical talks to Dr. Marcos Quintela Vasquez about the work he is conducting regarding the diagnosis and treatment of ovarian cancer in partnership with CEAT and Porvair Sciences.
Please tell us about CEAT, your project aims and how the group of partners was assembled?
The Cluster for Epigenomic and Antibody Drug Conjugate (ADC) Therapeutics (CEAT) is a Swansea University-led partnership between key multi-national players Glaxo Smith Kline (GSK), Cytiva and Bruker, together…

Click here to view the original article.